Pfizer spin-off SpringWorks embraces shelved therapies
“In a lot of ways, it starts with patient groups, who help us look at the landscape and understand where the science is that may not be organically happening in the industry right now,” said Lara Sullivan, founder and president of Pfizer spin-off SpringWorks.